MedPath

Theo-24

Theo-24 (theophylline anhydrous) Extended-release capsules 100, 200, 300, & 400 mg

Approved
Approval ID

7a108fa0-c230-475f-be93-6f864b98a410

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 30, 2017

Manufacturers
FDA

Endo Pharmaceuticals, Inc.

DUNS: 178074951

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

theophylline anhydrous

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52244-400
Application NumberANDA081034
Product Classification
M
Marketing Category
C73584
G
Generic Name
theophylline anhydrous
Product Specifications
Route of AdministrationORAL
Effective DateAugust 30, 2017
FDA Product Classification

INGREDIENTS (1)

THEOPHYLLINE ANHYDROUSActive
Quantity: 400 mg in 1 1
Code: 0I55128JYK
Classification: ACTIB

theophylline anhydrous

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52244-300
Application NumberANDA087944
Product Classification
M
Marketing Category
C73584
G
Generic Name
theophylline anhydrous
Product Specifications
Route of AdministrationORAL
Effective DateAugust 30, 2017
FDA Product Classification

INGREDIENTS (1)

THEOPHYLLINE ANHYDROUSActive
Quantity: 300 mg in 1 1
Code: 0I55128JYK
Classification: ACTIB

theophylline anhydrous

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52244-100
Application NumberANDA087942
Product Classification
M
Marketing Category
C73584
G
Generic Name
theophylline anhydrous
Product Specifications
Route of AdministrationORAL
Effective DateAugust 30, 2017
FDA Product Classification

INGREDIENTS (1)

THEOPHYLLINE ANHYDROUSActive
Quantity: 100 mg in 1 1
Code: 0I55128JYK
Classification: ACTIB

theophylline anhydrous

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52244-200
Application NumberANDA087943
Product Classification
M
Marketing Category
C73584
G
Generic Name
theophylline anhydrous
Product Specifications
Route of AdministrationORAL
Effective DateAugust 30, 2017
FDA Product Classification

INGREDIENTS (1)

THEOPHYLLINE ANHYDROUSActive
Quantity: 200 mg in 1 1
Code: 0I55128JYK
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Theo-24 - FDA Drug Approval Details